Publicaciones (20) Publicaciones de MARÍA ISABEL JIMÉNEZ ALONSO

2019

  1. Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386

2018

  1. The role of depression in mild cognitive impairment through the analysis with artificial neural networks

    ACM International Conference Proceeding Series

2017

  1. Methods in sand fly research

    Editorial Universidad de Alcalá

2013

  1. Aguacate: Rico en ácidos grasos monoinsaturados

    Integral: Vive mejor en un mundo mejor, Núm. 406, pp. 74-75

2008

  1. Cognitive impairment associated to leukoaraiosis: Its pathophysiology, clinical manifestations and treatment

    Revista de Neurologia, Vol. 47, Núm. 10, pp. 536-544

2007

  1. 13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding

    Helicobacter, Vol. 12, Núm. 3, pp. 231-237

2006

  1. Casos clínicos en digestivo

    Grupo Luzán 5

  2. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?

    Digestive and Liver Disease, Vol. 38, Núm. 4, pp. 254-259

  3. Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: Frequency and significance of borderline δ13CO2 values

    Alimentary Pharmacology and Therapeutics, Vol. 23, Núm. 2, pp. 275-280

2005

  1. Efectividad en la aplicación de tres protocolos de prevención y tratamiento de la osteoporosis en pacientes adultos con fibrosis quística

    Medicina Clinica, Vol. 125, Núm. 9, pp. 325-328

2004

  1. Estudio de la densidad mineral ósea en pacientes adultos con fibrosis quística

    Medicina Clinica, Vol. 123, Núm. 3, pp. 81-84

  2. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: A randomized, double-masked trial

    Clinical Gastroenterology and Hepatology, Vol. 2, Núm. 4, pp. 301-308

2003

  1. Comparación entre dos pruebas del aliento con 13C-urea para el diagnóstico de la infección por Helicobacter pylori: Espectrometría de masas frente a infrarojos

    Gastroenterologia y Hepatologia, Vol. 26, Núm. 3, pp. 141-146

2002

  1. Acute pancreatitis, hepatic cholestasis, and erythema nodosum induced by carbimazole treatment for Graves' disease

    Endocrine Journal, Vol. 49, Núm. 3, pp. 315-318

2000

  1. 13C-urea breath test for the diagnosis of Helicobacter pylori infection: Are basal samples necessary?

    European Journal of Gastroenterology and Hepatology, Vol. 12, Núm. 11, pp. 1201-1205

  2. 13C-Phenylalanine and 13C-Methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease

    Digestive and Liver Disease, Vol. 32, Núm. 3, pp. 226-232

  3. 13C-urea breath test for the diagnosis of Helicobacter pylori infection before treatment: Is citric acid necessary?

    Digestive and Liver Disease, Vol. 32, Núm. 1, pp. 20-24

1998

  1. Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients

    Nephron, Vol. 79, Núm. 1, pp. 55-60

1989

  1. Synthesis, structure and anti-fungal activity of 3-(2′-nitrovinyl)indoles

    European Journal of Medicinal Chemistry, Vol. 24, Núm. 1, pp. 39-42

1986

  1. Obstrucción pilórica por cuerpo extraño de origen intraperitoneal: aspectos endoscópicos.

    Revista espanola de las enfermedades del aparato digestivo, Vol. 69, Núm. 5, pp. 467-468